The Situation
When developing a payer value proposition for a COVID asset, our team recognized the limited clinical evidence and the market urgency to apply our integrated approach to develop and test the payer value proposition before deploying it in the field.
The Solution
Our Value and Evidence team brought in our marketing agency and our Data and Analytics team to develop a creative payer value proposition that was compelling, and evidence-driven.
The Results
We then conducted an advisory board with selected members of our syndicated KAM team to refine the document, before deploying it in the field.